Chordate presents Ozilia at LSX World Congress on April 29-30
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Chordate Medical is participating in this year's LSX World Congress in London on April 29-30. LSX World Congress is a leading event in the global life science sector, connecting innovative new solutions and start-up companies with major corporations and investors.
"LSX brings together potential investors in biotech, medtech, and healthtech from around the world in one place. It's a very fitting forum for us to present Ozilia as the latest development in migraine treatment," says Anders Weilandt, CEO of Chordate.
This year's edition of LSX World Congress is the tenth in its series. The purpose of the event is to connect capital with innovative developments to help create tomorrow's health solutions that can benefit more people.
"We already have the scientific evidence in place and are beginning to show proof of concept in several of our focus markets. The next step in the company's strategy is to find a buyer for the company. At LSX World Congress and other similar events we participate in during the spring, we find precisely the right target audience for us."